Insider Trading History of Sebelius Kathleen

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sebelius Kathleen since 2018. This trader's CIK number is 1654316. At the time of last reporting, Sebelius Kathleen was the Director of Humacyte, Inc.. (stock ticker symbol HUMA). Also see all insider trading activities at Humacyte, Inc..

Note that in the past Sebelius Kathleen also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Humacyte, Inc. (HUMA) by Sebelius Kathleen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 HUMA 50,000 $66,000 0 $0 0 $0
2024 HUMA 0 $0 5,182 $27,982 46,389 $127,750

Yearly summary of insider trading at Dermira, Inc. (DERM) by Sebelius Kathleen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 DERM 0 $0 0 $0 3,000 $0
2018 DERM 0 $0 0 $0 3,000 $0

Yearly summary of insider trading at Myovant Sciences Ltd. (MYOV) by Sebelius Kathleen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MYOV 5,000 $44,700 0 $0 0 $0


Insider trading activities at 3 companies by Sebelius Kathleen:

1. Humacyte, Inc. (HUMA)

2. Dermira, Inc. (DERM)

3. Myovant Sciences Ltd. (MYOV)

Table 1. Insider trading of Humacyte, Inc. (HUMA) by Sebelius Kathleen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-04-08 HUMA Buy 50,000 1.32 66,000
2024-09-10 HUMA Sale 5,182 5.40 27,982
2024-09-10 HUMA Option Ex 7,000 3.85 26,915
2024-06-14 HUMA Option Ex 39,389 2.56 100,835

Table 2. Insider trading of Dermira, Inc. (DERM) by Sebelius Kathleen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-06-12 DERM Option Ex 3,000 .00 0
2018-06-13 DERM Option Ex 3,000 .00 0

Table 3. Insider trading of Myovant Sciences Ltd. (MYOV) by Sebelius Kathleen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-06-12 MYOV Buy 5,000 8.94 44,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sebelius Kathleen (Director of Humacyte, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.